autism
IntegraGen Launches Genetic Screening Tool for Autism
IntegraGen Inc., a biotechnology company that bills itself as being "dedicated to molecular biomarker discovery," announced the launch of the ARISk risk assessment test for genetically screening for autism spectrum disorder (ASD). The test is gender-specific and looks at 65 genetic markers associated with ASD. It is designed to assess the risk of autism in children from multiplex families—siblings of children with ASD who are 6 to 30 months of age. The ARISk Test is lab-...